Crinetics Pharmaceuticals, Inc. Operating Lease, Liability, Noncurrent
Crinetics Pharmaceuticals, Inc. (CRNX) had Operating Lease, Liability, Noncurrent of $40.61 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-03
- 2026-06-30: Operating Lease, Liability, Noncurrent $40.61M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $41.32M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $42.05M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $42.70M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $40.61M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $41.32M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $42.05M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $42.70M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $43.33M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $43.94M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $44.57M 10-K · filed 2026-02-26 |
| 2024-09-30 | $45.13M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $45.87M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $46.71M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $47.55M 10-K · filed 2025-02-27 |
| 2023-09-30 | $48.18M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.46M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.74M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $2.02M 10-K · filed 2024-02-28 |
| 2022-09-30 | $2.30M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.56M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $2.82M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.07M 10-K · filed 2023-02-28 |
| 2021-09-30 | $3.32M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $3.56M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $3.79M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.01M 10-K · filed 2022-03-30 |
| 2020-09-30 | $4.23M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $4.44M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $4.65M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $4.85M 10-K · filed 2021-03-30 |
| 2019-09-30 | $5.04M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $5.23M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $5.40M 10-Q · filed 2019-05-13 |